Well work with you to adjust it based on your experience and goals
Retatrutide is a next-generation weight loss injection developed by Eli Lilly (same manufacturer as Mounjaro), designed to target three separate hormone receptors in the body: the GLP-1 receptor, the GIP receptor, and the glucagon receptor
problems with your gallbladder, kidneys, or pancreas
They can help determine if the medication is appropriate and which prescription option is best given your health status
Cardiometabolic Health at Eli Lilly
102 Compared with the structure of human GLP-1(7-36), the amino acid sequence of albiglutide contains an arginine at position 8 (in GLP-1, this residue is lysine), and two modified GLP-1 peptide chains are fused to human serum albumin (HSA), thereby greatly extending its half-life